Markets › United States › NAS › ALZN

Alzamend Neuro Inc

NAS:ALZNHealthcarenasdaq_composite

$1.31−1.34%LiveIn session · ≈ AED 4.82 · Market cap $6.33M · Next earnings Wed 30 Dec

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Return on equity	−250.7%	−92.6%	−488.5%	383.5%	−113.8%	−1,196.4%	−1,196.4%	+0.0 pts
Return on assets	−173.3%	−85.2%	−251.5%	−1,575.0%	−98.1%	−421.9%	−421.9%	+0.0 pts
Return on capital employed	−246.0%	−92.3%	−488.3%	383.1%	−113.3%	−1,195.7%	—	—
Debt / equity	0.2×	0.0×	0.0×	−0.1×	0.0×	0.0×	0.0×	—
Debt / assets	11.5%	0.0%	0.0%	47.6%	0.0%	0.0%	—	—
Interest coverage	−31.2×	−264.8×	−1,931.0×	−983.8×	−249.4×	1,324.5×	—	—
Current ratio	3.2×	12.4×	2.0×	0.1×	6.6×	1.3×	1.3×	+0.0%
Quick ratio	3.3×	12.4×	2.0×	0.1×	6.6×	1.3×	—	—
Cash ratio	2.1×	12.1×	1.8×	0.1×	6.2×	0.5×	0.5×	+0.0%
Asset turnover	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Inventory turnover	0.0×	—	—	—	—	—	—	—
Receivables turnover	0.0×	—	—	—	—	—	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—